These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 839364)
1. Treatment of congenital virilizing adrenal hyperplasia patients with single and multiple daily doses of prednisone. Huseman CA; Varma MM; Blizzard RM; Johanson A J Pediatr; 1977 Apr; 90(4):538-42. PubMed ID: 839364 [TBL] [Abstract][Full Text] [Related]
2. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression. Lee PA; Urban MD; Gutai JP; Migeon CJ Horm Res; 1980; 13(6):347-57. PubMed ID: 7196877 [TBL] [Abstract][Full Text] [Related]
3. Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia. Frisch H; Parth K; Schober E; Swoboda W Arch Dis Child; 1981 Mar; 56(3):208-13. PubMed ID: 7212759 [TBL] [Abstract][Full Text] [Related]
4. Management of congenital adrenal hyperplasia using serum dehydroepiandrosterone sulfate and 17-hydroxyprogesterone concentrations. Golden MP; Lippe BM; Kaplan SA; Lavin N; Slavin J Pediatrics; 1978 Jun; 61(6):867-71. PubMed ID: 149950 [TBL] [Abstract][Full Text] [Related]
5. The relationships between serum concentrations of 17OH-progesterone and other serum and urinary steroids in patients with congenital adrenal hyperplasia. Hughes IA; Winter JS J Clin Endocrinol Metab; 1978 Jan; 46(1):98-104. PubMed ID: 752027 [TBL] [Abstract][Full Text] [Related]
14. Hormonal and clinical responses to prednisone treatment in adolescents with congenital adrenal hyperplasia. Zipf WB; Bacon GE; Kelch RP Horm Res; 1980; 12(4):206-17. PubMed ID: 6446517 [TBL] [Abstract][Full Text] [Related]
15. Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia. McKenna TJ; Jennings AS; Liddle GW; Burr IM J Clin Endocrinol Metab; 1976 May; 42(5):918-25. PubMed ID: 178685 [TBL] [Abstract][Full Text] [Related]
16. Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth. Linder B; Feuillan P; Chrousos GP J Clin Endocrinol Metab; 1989 Jul; 69(1):191-5. PubMed ID: 2543690 [TBL] [Abstract][Full Text] [Related]
17. Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia. Strott CA; Yoshimi T; Lipsett MB J Clin Invest; 1969 May; 48(5):930-9. PubMed ID: 4305376 [TBL] [Abstract][Full Text] [Related]
18. Experience with long-term therapy in congenital adrenal hyperplasia. Brook CG; Zachmann M; Prader A; Mürset G J Pediatr; 1974 Jul; 85(1):12-9. PubMed ID: 4851964 [No Abstract] [Full Text] [Related]
19. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion. Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467 [TBL] [Abstract][Full Text] [Related]
20. Congenital adrenal hyperplasia and diabetes mellitus in a woman aged 71 years. Hoff W van't ; Bicknell EJ Acta Endocrinol (Copenh); 1972 Feb; 69(2):329-34. PubMed ID: 5066842 [No Abstract] [Full Text] [Related] [Next] [New Search]